Launch KarXT in the U.S. for the treatment of schizophrenia in adults
Delivered by the deadline
AI-confirmed · human review in progress Independent AI checks agreed on primary SEC or regulator evidence. Records are now being reviewed by hand, starting with those our customers order.
- Announced
- 22 Dec 2023
- Due
- 31 Dec 2024
- Delivered
- October 2024
- Deadline
- Met
- Late
- Not met
- Today
What the company said
“KarXT is expected to launch in late 2024 in the U.S. as a treatment for schizophrenia in adults.”
What we found
Evidence strength A What the grades mean
Bristol Myers Squibb launched Cobenfy (formerly KarXT) in the U.S. for the treatment of schizophrenia in adults in October 2024, following FDA approval in September 2024.
-
A Bristol Myers Squibb Co. 10-Q filed 2025-04-24
“Cobenfy was approved by the FDA in September 2024 and launched in October 2024.” ✓ confirmed on the page
Market reaction: the shares moved -3.0% against the S&P 500 over the three sessions around the disclosure (23 Apr 2025 to 28 Apr 2025). What this measures
Checked 5 Oct 2026.
Commitment DNA
The structured record of this commitment. Fields the company did not state are left blank rather than guessed.
- Event type
- Commercial launch
- Indicative materiality
- Medium rules
- Action
- Launch
- Deliverable
- KarXT launch in the U.S.
- Where
- U.S.
- Language
- Expected (“expects”, “plans”)
- In the company’s control
- Medium
- Specificity
- Medium
- Depends on
- Regulatory
How this entry was checked
- Commitment recordedThe company's words were matched word for word against the filing.
- First checkAn AI model, Gemini (Google), read the company's later filings and recorded the outcome with a quoted passage.
- Second check: agreesA different AI model, Claude (Anthropic), re-read the evidence without being told the outcome and reached the same answer.
Confirmed. This outcome counts towards the company's Kept Score. How verification works
Are you Bristol Myers Squibb Co.? You can publish an official statement next to this entry, free. Add a statement.
Is something here wrong or out of date? Companies and readers can ask us to check it. Please bring a link to a public source.
Report an error in this entry Reference: KI-C-2023-BMY-004811 · Corrections policy